Journal
EUROPEAN HEART JOURNAL
Volume 39, Issue 11, Pages 925-933Publisher
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehx486
Keywords
Angina pectoris; Refractory angina; Chronic angina; Coronary artery disease; Coronary sinus; Quality-of-life; Residual angina; Microcirculation; Syndrome X
Categories
Ask authors/readers for more resources
Despite available pharmacological and interventional therapies, refractory angina is a common and disabling clinical condition, and a major public health problem, which affects patients' quality-of-life, and has a significant impact upon health care resources. Persistent angina is common not only in patients who are not good candidates for revascularization, but also in patients following successful revascularization. Clearly, there is a need for additional treatment options for refractory angina beyond currently available pharmacological and interventional therapies. It is of pivotal importance, in this condition, to practice a patient-centred health assessment approach, measuring success of a new therapy by its effects on patients' symptoms, functional status, and quality-of-life, rather than hard clinical endpoints as used in clinical studies. The coronary sinus Reducer is a novel technology designed to reduce disabling symptoms and improve quality-of-life of patients suffering from refractory angina. This review serves to update the clinician as to current evidence and future perspectives of the optimal utilization of this innovative technology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available